Information de reference pour ce titreAccession Number: | 00005082-201107000-00010.
|
Author: | Lee, Christopher S. PhD, RN; Moser, Debra K. DNSc, RN; Lennie, Terry A. PhD, RN; Tkacs, Nancy C. PhD, RN; Margulies, Kenneth B. MD; Riegel, Barbara DNSc, RN
|
Institution: | Christopher S. Lee, PhD, RN Oregon Health & Science University School of Nursing, Portland. Debra K. Moser, DNSc, RN University of Kentucky College of Nursing, Lexington. Terry A. Lennie, PhD, RN University of Kentucky College of Nursing, Lexington. Nancy C. Tkacs, PhD, RN University of Pennsylvania School of Nursing, Philadelphia. Kenneth B. Margulies, MD University of Pennsylvania School of Medicine, Philadelphia. Barbara Riegel, DNSc, RN University of Pennsylvania School of Nursing, Philadelphia.
|
Title: | |
Source: | Journal of Cardiovascular Nursing. 26(4):321-328, July/August 2011.
|
Abstract: | Background: Self-care is believed to improve heart failure (HF) outcomes, but the mechanisms by which such improvement occurs remain unclear.
Methods: We completed a secondary analysis of cross-sectional data collected on adults with symptomatic HF to test our hypothesis that effective self-care is associated with less myocardial stress and systemic inflammation. Multivariate logistic regression modeling was used to determine if better HF self-care reduced the odds of having serum levels of amino-terminal pro-B-type natriuretic peptide and soluble tumor necrosis factor [alpha] receptor type 1 at or greater than the sample median. Heart failure self-care was measured using the Self-care of Heart Failure Index.
Results: The sample (n = 168) was predominantly male (65.5%), and most (50.6%) had New York Heart Association III HF (mean left ventricular ejection fraction, 34.9% [SD, 14.0%]); mean age was 58.8 (SD, 11.5) years. Self-care management was an independent factor in the model (block [chi]2 = 14.74; P = .005) after controlling for pertinent confounders (model [chi]2 = 52.15; P < .001). Each 1-point increase in self-care management score (range, 15-100) was associated with a 12.7% reduction in the odds of having levels of both biomarkers at or greater than the sample median (adjusted odds ratio, 0.873; 95% confidence interval, 0.77-0.99; P = .03).
Conclusion: Better self-care management was associated with reduced odds of myocardial stress and systemic inflammation over and above pharmacological therapy and other common confounding factors. Teaching HF patients early symptom recognition and self-care of symptoms may decrease myocardial stress and systemic inflammation.
(C) 2011 Lippincott Williams & Wilkins, Inc.
|
Author Keywords: | adherence; biomarkers; heart failure; self-care.
|
References: | 1. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20(1):248-254.
2. Seta Y, Shan K, Bozkurt B, Oral H, Mann DL. Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail. 1996;2(3):243-249.
3. Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J. 2003;24(19):1735-1743.
4. Rothenburger M, Wichter T, Schmid C, et al. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. J Heart Lung Transplant. 2004;23(10):1189-1197.
5. Rauchhaus M, Doehner W, Francis DP, et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 2000;102(25):3060-3067.
6. Ueland T, Kjekshus J, Froland SS, et al. Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients. J Am Coll Cardiol. 2005;46(11):2018-2021.
7. Lee CS, Tkacs NC, Riegel B. The influence of heart failure self-care on health outcomes: hypothetical cardioprotective mechanisms. J Cardiovasc Nurs. 2009;24(3):179-189.
8. Riegel B, Carlson B, Moser DK, Sebern M, Hicks FD, Roland V. Psychometric testing of the Self-care of Heart Failure Index. J Card Fail. 2004;10(4):350-360.
9. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2006;12(1):10-38.
10. Ditewig JB, Blok H, Havers J, van Veenendaal H. Effectiveness of self-management interventions on mortality, hospital readmissions, chronic heart failure hospitalization rate and quality of life in patients with chronic heart failure: a systematic review. Patient Educ Couns. 2010;78(3):297-315.
11. Riegel B, Moser DK, Anker SD, et al. State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. Circulation. 2009;120(12):1141-1163.
12. Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008;358(20):2148-2159.
13. Heo S, Lennie TA, Moser DK, Riegel B, Chung M. Gender differences in and factors related to self-care behaviors: a cross-sectional, correlational study of patients with heart failure. Int J Nurs Stud. 2008;45(12):1807-1815.
14. Moser DK, Chung ML, Riegel B, Rayens MK, Lennie TA. Nonadherence is a mediator of the link between depressive symptoms, and rehospitalization or mortality in patients with heart failure. Circulation. 2006;144(suppl):II-518.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
16. Zethelius B, Berglund L, Sundstrom J, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med. 2008;358(20):2107-2116.
17. Bruins S, Fokkema MR, Romer JW, et al. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem. 2004;50(11):2052-2058.
18. Dibbs Z, Thornby J, White BG, Mann DL. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol. 1999;33(7):1935-1942.
19. Block G, Dietrich M, Norkus E, et al. Intraindividual variability of plasma antioxidants, markers of oxidative stress, C-reactive protein, cotinine, and other biomarkers. Epidemiology. 2006;17(4):404-412.
20. Apple FS, Wu AH, Jaffe AS, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: analytical issues for biomarkers of heart failure. Circulation. 2007;116(5):e95-e98.
21. Allen LA, Michael Felker G. Multi-marker strategies in heart failure: clinical and statistical approaches. Heart Fail Rev. 2009.
22. Loke I, Squire IB, Davies JE, Ng LL. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate. Eur J Heart Fail. 2003;5(5):599-606.
23. Das SR, Drazner MH, Dries DL, et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation. 2005;112(14):2163-2168.
24. Cowie MR, Jourdain P, Maisel A, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J. 2003;24(19):1710-1718.
25. Tang WH, Girod JP, Lee MJ, et al. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation. 2003;108(24):2964-2966.
26. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001;103(16):2055-2059.
27. Gundogdu F, Bozkurt E, Kiziltunc A, et al. The effect of beta-blocker (carvedilol) therapy on N-terminal pro-brain natriuretic peptide levels and echocardiographic findings in patients with congestive heart failure. Echocardiography. 2007;24(2):113-117.
28. Gullestad L, Aukrust P, Ueland T, et al. Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. J Am Coll Cardiol. 1999;34(7):2061-2067.
29. Fliser D, Buchholz K, Haller H. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation. 2004;110(9):1103-1107.
30. Sola S, Mir MQ, Rajagopalan S, Helmy T, Tandon N, Khan BV. Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure. J Card Fail. 2005;11(8):607-612.
31. Allison PD. Multiple Regression: A Primer. Thousand Oaks, CA: Pine Forge Press; 1999.
32. Riegel B, Dickson VV. A situation-specific theory of heart failure self-care. J Cardiovasc Nurs. 2008;23(3):190-196.
33. Lee CS, Moser DK, Lennie TA, Riegel B. Event-free survival in adults with heart failure who engage in self-care management. Heart Lung. 2011;40(1):12-20.
34. Goetze JP. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clin Chem. 2004;50(9):1503-1510.
35. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev. 2003;24(3):341-356.
36. Anker SD, von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart. 2004;90(4):464-470.
37. Torre-Amione G. Immune activation in chronic heart failure. Am J Cardiol. 2005;95(11A):3C-8C; discussion 38C-40C.
38. Aukrust P, Gullestad L, Ueland T, Damas JK, Yndestad A. Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications. Ann Med. 2005;37(2):74-85.
39. Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res. 2004;94(12):1543-1553.
40. Alvelos M, Ferreira A, Bettencourt P, et al. The effect of dietary sodium restriction on neurohumoral activity and renal dopaminergic response in patients with heart failure. Eur J Heart Fail. 2004;6(5):593-599.
41. Patel J, Smith M, Heywood JT. Optimal use of diuretics in patients with heart failure. Curr Treat Options Cardiovasc Med. 2007;9(4):332-342.
42. Peschel T, Schonauer M, Thiele H, Anker SD, Schuler G, Niebauer J. Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure. Eur J Heart Fail. 2003;5(5):609-614.
43. Katz AM. Physiology of the Heart. Forth ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006.
44. Kelley KW, Bluthe RM, Dantzer R, et al. Cytokine-induced sickness behavior. Brain Behav Immun. 2003;17 suppl 1:S112-S118.
45. Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun. 2007;21(2):153-160.
46. Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26(1):1-7.
47. Rockwell JM, Riegel B. Predictors of self-care in persons with heart failure. Heart Lung. 2001;30(1):18-25.
48. Schnell-Hoehn KN, Naimark BJ, Tate RB. Determinants of self-care behaviors in community-dwelling patients with heart failure. J Cardiovasc Nurs. 2009;24(1):40-47.
49. Rector TS, Anand IS, Cohn JN. Relationships between clinical assessments and patients' perceptions of the effects of heart failure on their quality of life. J Card Fail. 2006;12(2):87-92.
50. Shah MR, Hasselblad V, Stinnett SS, et al. Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure. Eur J Heart Fail. 2002;4(3):297-304.
51. Musil CM, Morris DL, Haug MR, Warner CB, Whelan AT. Recurrent symptoms: well-being and management. Soc Sci Med. 2001;52(11):1729-1740.
52. Zambroski C. Self-care at the end of life in patients with heart failure. J Cardiovasc Nurs. 2008;23(3):266-276.
53. Morrow DA, de Lemos JA. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation. 2007;115(8):949-952.
54. Bettencourt P, Frioes F, Azevedo A, et al. Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure. Int J Cardiol. 2004;93(1):45-48.
55. Clerico A, Del Ry S, Maffei S, Prontera C, Emdin M, Giannessi D. The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex. Clin Chem Lab Med. 2002;40(4):371-377.
56. Lee CS, Suwanno J, Riegel B. The relationship between self-care and health status domains in Thai patients with heart failure. Eur J Cardiovasc Nurs. 2009;8(4):259-266.
57. Shadish WR, Cook TD, Campbell DT. Experimental and Quasi-Experimental Designs for General Causal Inference. Boston, MA: Houghton Mifflin Company; 2002.
58. Cameron J, Worrall-Carter L, Driscoll A, Stewart S. Measuring self-care in chronic heart failure: a review of the psychometric properties of clinical instruments. J Cardiovasc Nurs. 2009;24(6):E10-E22.
|
Language: | English.
|
Document Type: | ARTICLES: Heart Failure.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0889-4655
|
NLM Journal Code: | jcn, 8703516
|
DOI Number: | https://dx.doi.org/10.1097/JCN.0...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|